SG Americas Securities LLC Has $158,000 Stock Holdings in MiMedx Group, Inc. (NASDAQ:MDXG)

SG Americas Securities LLC trimmed its stake in MiMedx Group, Inc. (NASDAQ:MDXG) by 63.9% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 22,794 shares of the company’s stock after selling 40,261 shares during the quarter. SG Americas Securities LLC’s holdings in MiMedx Group were worth $158,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. AJOVista LLC acquired a new stake in MiMedx Group in the fourth quarter worth $25,000. Headlands Technologies LLC bought a new position in shares of MiMedx Group in the first quarter valued at $27,000. Entropy Technologies LP bought a new position in shares of MiMedx Group in the first quarter valued at $99,000. Loudon Investment Management LLC bought a new position in shares of MiMedx Group in the fourth quarter valued at $105,000. Finally, Shell Asset Management Co. bought a new position in shares of MiMedx Group in the first quarter valued at $113,000. 79.15% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms have weighed in on MDXG. StockNews.com lowered shares of MiMedx Group from a “strong-buy” rating to a “buy” rating in a research note on Monday, August 5th. HC Wainwright reiterated a “buy” rating and issued a $11.00 target price on shares of MiMedx Group in a research note on Wednesday, May 1st. Craig Hallum reduced their target price on shares of MiMedx Group from $14.00 to $12.00 and set a “buy” rating for the company in a research note on Thursday, August 1st. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $11.00 target price on shares of MiMedx Group in a research note on Thursday, August 1st. Six investment analysts have rated the stock with a buy rating, According to MarketBeat, MiMedx Group currently has a consensus rating of “Buy” and an average target price of $12.00.

MiMedx Group Price Performance

Shares of NASDAQ:MDXG opened at $6.90 on Friday. The company has a 50 day moving average of $6.86 and a 200 day moving average of $7.26. The stock has a market cap of $1.02 billion, a P/E ratio of 15.68 and a beta of 1.98. MiMedx Group, Inc. has a 12 month low of $5.57 and a 12 month high of $9.27. The company has a current ratio of 3.85, a quick ratio of 2.71 and a debt-to-equity ratio of 0.11.

MiMedx Group (NASDAQ:MDXG) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $0.08 EPS for the quarter, meeting the consensus estimate of $0.08. The company had revenue of $87.21 million during the quarter, compared to analysts’ expectations of $88.44 million. MiMedx Group had a net margin of 23.63% and a return on equity of 34.24%. As a group, sell-side analysts forecast that MiMedx Group, Inc. will post 0.32 EPS for the current fiscal year.

MiMedx Group Profile

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins.